Literature DB >> 9973453

Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes.

U D'Oro1, J D Ashwell.   

Abstract

A widely accepted model for regulation of the Lck tyrosine kinase is that it is activated by CD45-mediated dephosphorylation of its COOH-terminal negative regulatory tyrosine (Tyr505). Previous work from our laboratory, however, found that despite hyperphosphorylation of Tyr505, the activity of Lck from CD45- T cell lines was actually increased due to hyperphosphorylation of the positive regulatory tyrosine, residue 394. To avoid potential complications introduced by transformed cells, in this study we have characterized the effect of CD45 on Lck activity in normal cells. Lck in thymocytes from CD45-/- mice was hyperphosphorylated on tyrosine residues. Importantly, and in disagreement with the model that CD45 only activates Lck in vivo, the kinase activity of Lck from cells lacking CD45 was substantially increased. These results support a model in which CD45 dephosphorylates both Tyr505 and Tyr394, the net effect in normal thymocytes being a decrease in enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973453

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Membrane domains and the immunological synapse: keeping T cells resting and ready.

Authors:  Michael L Dustin
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice.

Authors:  M Baker; J Gamble; R Tooze; D Higgins; F T Yang; P C O'Brien; N Coleman; S Pingel; M Turner; D R Alexander
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  EMBO WORKSHOP REPORT: lymphocyte antigen receptor and coreceptor signaling Siena, Italy, November 6-10, 1999.

Authors:  C T Baldari; J L Telford; O Acuto
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

Review 4.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

5.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

6.  T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster.

Authors:  Rajat Varma; Gabriele Campi; Tadashi Yokosuka; Takashi Saito; Michael L Dustin
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

Review 7.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

8.  Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses.

Authors:  Michelle L Hermiston; Julie Zikherman; Allison L Tan; Viola C Lam; Nicole M Cresalia; Nir Oksenberg; Nira Goren; David Brassat; Jorge R Oksenberg; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

9.  Increased sensitivity to antigen in high avidity CD8(+) T cells results from augmented membrane proximal T-cell receptor signal transduction.

Authors:  Sharad K Sharma; Martha A Alexander-Miller
Journal:  Immunology       Date:  2011-04-19       Impact factor: 7.397

10.  The protein tyrosine phosphatase CD45 is required for interleukin 6 signaling in U266 myeloma cells.

Authors:  Qun Zhou; Yuan Yao; Solveig G Ericson
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.